Compare · DXCM vs OSRH
DXCM vs OSRH
Side-by-side comparison of DexCom Inc. (DXCM) and OSR Holdings Inc. (OSRH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and OSRH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $28.08B, about 1901.3x OSRH ($14.8M).
- DXCM has been more active in the news (30 items in the past 4 weeks vs 7 for OSRH).
- DXCM has more recent analyst coverage (25 ratings vs 0 for OSRH).
- Company
- DexCom Inc.
- OSR Holdings Inc.
- Price
- -
- -
- Market cap
- $28.08B
- $14.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- 2023
- News (4w)
- 30
- 7
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Latest DXCM
- Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
- Director Altman Steven R was granted 5,565 shares (SEC Form 4)
- Director Augustinos Nicholas was granted 5,575 shares (SEC Form 4)
- Director Malady Kyle was granted 5,575 shares, increasing direct ownership by 25% to 28,242 units (SEC Form 4)
- Director Heller Bridgette P was granted 5,575 shares, increasing direct ownership by 22% to 30,582 units (SEC Form 4)
- Director Osterloh Albert Frederick Iv was granted 1,630 shares, increasing direct ownership by 23% to 8,691 units (SEC Form 4)
- Director Foletta Mark G was granted 6,331 shares (SEC Form 4)
- Director Driscoll Rimma was granted 5,605 shares, increasing direct ownership by 48% to 17,319 units (SEC Form 4)
- Director Ashley Euan A. was granted 5,565 shares, increasing direct ownership by 78% to 12,731 units (SEC Form 4)
- Director Collins Richard Alexander was granted 5,605 shares (SEC Form 4)
Latest OSRH
- CEO Statement to Shareholders
- OSR Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction
- SEC Form DEF 14A filed by OSR Holdings Inc.
- SEC Form 10-Q filed by OSR Holdings Inc.
- CEO Statement to Shareholders
- SEC Form PRE 14A filed by OSR Holdings Inc.
- Amendment: OSR Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream
- Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target